News ChengDu ShengNuo Biotec Co.,Ltd.

Equities

688117

CNE1000051M8

End-of-day quote Shanghai S.E. Other stock markets 23:00:00 06/06/2024 BST			5-day change	1st Jan Change
23.97 ^CNY	-0.33%		-4.62%	-15.00%

05-07	Sheng Nuo Biotec's Unit Gets Nod to Produce Posaconazole Injection	MT
04-22	ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Summary

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Sheng Nuo Biotec's Unit Gets Nod to Produce Posaconazole Injection	05-07	MT
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	04-22	CI
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	02-23	CI
Cheng Du Sheng Nuo Biotec Completes US FDA Filing For Constipation Drug API	11-15	MT
Biocells Biotechnology Co., Ltd. announced that it has received funding from ChengDu ShengNuo Biotec Co.,Ltd., Xiamen Gaoxin Kechuang Angel Venture Capital Co., Ltd., Green Pine Capital Partners Co., Ltd.	30/10/23	CI
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	30/10/23	CI
ChengDu ShengNuo Biotec Co.,Ltd. cancelled the transaction announced on May 16, 2023	19/10/23	CI
Sheng Nuo Biotec's Unit Gets Nod to Amend Usage of Carbetocin Injection	07/09/23	MT
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	16/08/23	CI
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	25/04/23	CI
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	24/02/23	CI
Three Cheng Du Sheng Nuo Biotec Execs to Divest Stakes	04/11/22	MT
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	27/10/22	CI
GermanLitho announced that it has received funding from Jingzhou Huaying Capital Venture Capital Management Partnership Enterprise (L.P.), ChengDu ShengNuo Biotec Co.,Ltd.	15/09/22	CI
WNL Biomedtech announced that it has received funding from Huaying Capital, ChengDu ShengNuo Biotec Co.,Ltd.	15/09/22	CI
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022	24/08/22	CI
ChengDu ShengNuo Biotec Co.,Ltd.(SHSE:688117) added to Shanghai Stock Exchange Composite Index	03/06/22	CI
ChengDu ShengNuo Biotec Co.,Ltd.(SHSE:688117) added to Shanghai Stock Exchange A Share Index	03/06/22	CI
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	26/04/22	CI
ChengDu ShengNuo Biotec Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	25/02/22	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News ChengDu ShengNuo Biotec Co.,Ltd.

Equities

688117

CNE1000051M8

Summary

Filters